BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11850369)

  • 1. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.
    Taylor B; Miller E; Lingam R; Andrews N; Simmons A; Stowe J
    BMJ; 2002 Feb; 324(7334):393-6. PubMed ID: 11850369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between MMR vaccination level and the number of new cases of autism in children].
    Mrozek-Budzyn D; Kiełtyka A
    Przegl Epidemiol; 2008; 62(3):597-604. PubMed ID: 19108524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lack of association between MMR vaccination and the incidence of autism in children: a case-control study].
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Przegl Epidemiol; 2009; 63(1):107-12. PubMed ID: 19522237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
    Hviid A; Hansen JV; Frisch M; Melbye M
    Ann Intern Med; 2019 Apr; 170(8):513-520. PubMed ID: 30831578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MMR Vaccine and Autism.
    DeStefano F; Shimabukuro TT
    Annu Rev Virol; 2019 Sep; 6(1):585-600. PubMed ID: 30986133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism.
    Jain A; Marshall J; Buikema A; Bancroft T; Kelly JP; Newschaffer CJ
    JAMA; 2015 Apr; 313(15):1534-40. PubMed ID: 25898051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closer look at autism and the measles-mumps-rubella vaccine.
    Hensley E; Briars L
    J Am Pharm Assoc (2003); 2010; 50(6):736-41. PubMed ID: 21071320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States.
    Smith MJ; Ellenberg SS; Bell LM; Rubin DM
    Pediatrics; 2008 Apr; 121(4):e836-43. PubMed ID: 18381512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
    Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
    Vaccine; 2012 Jun; 30(28):4292-8. PubMed ID: 22521285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
    Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O
    BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMR: marginalised, misrepresented and rejected? Autism: a focus group study.
    Hilton S; Hunt K; Petticrew M
    Arch Dis Child; 2007 Apr; 92(4):322-7. PubMed ID: 17376937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMR vaccine and autism.
    Bedford HE; Elliman DA
    BMJ; 2010 Feb; 340():c655. PubMed ID: 20124364
    [No Abstract]   [Full Text] [Related]  

  • 17. The MMR Vaccine Is Not Associated With Risk for Autism.
    Ann Intern Med; 2019 Apr; 170(8):. PubMed ID: 30831599
    [No Abstract]   [Full Text] [Related]  

  • 18. MMR: where are we now?
    Elliman D; Bedford H
    Arch Dis Child; 2007 Dec; 92(12):1055-7. PubMed ID: 17626143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan.
    Uchiyama T; Kurosawa M; Inaba Y
    J Autism Dev Disord; 2007 Feb; 37(2):210-7. PubMed ID: 16865547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.